William T. Bradner

2.9k total citations
71 papers, 2.2k citations indexed

About

William T. Bradner is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, William T. Bradner has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 22 papers in Toxicology and 20 papers in Organic Chemistry. Recurrent topics in William T. Bradner's work include Bioactive Compounds and Antitumor Agents (22 papers), Cancer therapeutics and mechanisms (19 papers) and Microbial Natural Products and Biosynthesis (15 papers). William T. Bradner is often cited by papers focused on Bioactive Compounds and Antitumor Agents (22 papers), Cancer therapeutics and mechanisms (19 papers) and Microbial Natural Products and Biosynthesis (15 papers). William T. Bradner collaborates with scholars based in United States, Germany and United Kingdom. William T. Bradner's co-authors include Stanley T. Crooke, John E. Schurig, James Bush, William A. Remers, B H Long, J. J. Catino, William C. Rose, Terrence W. Doyle, Donald A. Clarke and Bhashyam S. Iyengar and has published in prestigious journals such as Nature, Science and Annals of the New York Academy of Sciences.

In The Last Decade

William T. Bradner

71 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William T. Bradner United States	22	963	721	510	370	355	71	2.2k
Claude Vézina Canada	18	2.0k 2.1×	492 0.7×	346 0.7×	588 1.6×	100 0.3×	44	3.1k
John A. Hadfield United Kingdom	22	1.1k 1.1×	1.6k 2.2×	356 0.7×	431 1.2×	190 0.5×	63	3.0k
Hitoshi Sezaki Japan	33	1.2k 1.3×	312 0.4×	700 1.4×	231 0.6×	116 0.3×	121	3.1k
Masaaki Ishizuka Japan	35	2.0k 2.1×	963 1.3×	853 1.7×	919 2.5×	162 0.5×	141	4.0k
Giuseppe Cassinelli Italy	23	863 0.9×	542 0.8×	396 0.8×	335 0.9×	78 0.2×	48	1.7k
Enrico Mihich United States	29	1.1k 1.1×	202 0.3×	950 1.9×	195 0.5×	70 0.2×	193	2.9k
Thomas Robert France	27	1.1k 1.2×	472 0.7×	330 0.6×	356 1.0×	54 0.2×	98	2.5k
Takeo Usui Japan	36	2.0k 2.1×	1.1k 1.5×	387 0.8×	773 2.1×	87 0.2×	149	3.7k
Thomas C. Rowe United States	24	3.2k 3.4×	691 1.0×	1.2k 2.4×	293 0.8×	593 1.7×	44	4.2k
Asher Begleiter Canada	31	1.5k 1.5×	494 0.7×	496 1.0×	65 0.2×	506 1.4×	99	2.5k

Countries citing papers authored by William T. Bradner

Since Specialization

Citations

This map shows the geographic impact of William T. Bradner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William T. Bradner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William T. Bradner more than expected).

Fields of papers citing papers by William T. Bradner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William T. Bradner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William T. Bradner. The network helps show where William T. Bradner may publish in the future.

Co-authorship network of co-authors of William T. Bradner

This figure shows the co-authorship network connecting the top 25 collaborators of William T. Bradner. A scholar is included among the top collaborators of William T. Bradner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William T. Bradner. William T. Bradner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bradner, William T.. (2001). Mitomycin C: a clinical update. Cancer Treatment Reviews. 27(1). 35–50. 267 indexed citations

Bradner, William T., et al.. (1990). Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyidithio) ethyl] mitomycin C (BMY-25067). Investigational New Drugs. 8(S1). S1–S7. 8 indexed citations

Al-Baker, Salaam, et al.. (1990). Antitumor and DNA-binding properties of a group of oligomeric complexes of platinum(II) and platinum(IV). Journal of Medicinal Chemistry. 33(8). 2184–2188. 14 indexed citations

Schurig, John E., William T. Bradner, George A. Basler, & William C. Rose. (1989). Experimental antitumor activity of BMY-28090, a new antitumor antibiotic. Investigational New Drugs. 7(2-3). 173–178. 10 indexed citations

Matson, James A., et al.. (1989). Antitumor activity of chrysomycins M and V.. The Journal of Antibiotics. 42(9). 1446–1448. 18 indexed citations

Remers, William A., et al.. (1989). Preparation and antitumor activity of additional mitomycin A analogs. Journal of Medicinal Chemistry. 32(3). 703–708. 13 indexed citations

Vyas, Dolatrai M., Daniel A. Benigni, William C. Rose, William T. Bradner, & Terrence W. Doyle. (1989). Synthesis and in vivo antitumor activity of novel mitomycin A disulfide analogs.. The Journal of Antibiotics. 42(7). 1199–1201. 3 indexed citations

Bradner, William T., et al.. (1985). Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.. PubMed. 45(12 Pt 1). 6475–81. 14 indexed citations

Bradner, William T., et al.. (1984). Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.. PubMed. 44(12 Pt 1). 5619–23. 7 indexed citations

10.

Rose, William C., et al.. (1983). Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.. PubMed. 43(4). 1504–10. 24 indexed citations

11.

Bush, James, William T. Bradner, & Ken‐ichi Tomita. (1982). Production and biological activity of marcellomycin, an antitumor anthracycline antibiotic, and taxonomy of the producing organism.. The Journal of Antibiotics. 35(9). 1174–1183. 3 indexed citations

12.

Schmitz, H, et al.. (1982). Structural modifications of anguidin and antitumor activities of its analogs. Journal of Medicinal Chemistry. 25(5). 579–589. 20 indexed citations

13.

Nettleton, Donald E., et al.. (1981). Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E.. The Journal of Antibiotics. 34(12). 1544–1555. 66 indexed citations

14.

Crooke, Stanley T., et al.. (1981). Tallysomycin, A Third Generation Bleomycin Analog. Recent results in cancer research. 76. 83–90. 1 indexed citations

15.

Doyle, Terrence W., et al.. (1979). The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.. PubMed. 15(2). 341–56. 16 indexed citations

16.

Crooke, Stanley T. & William T. Bradner. (1976). Bleomycin, a review.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(5). 333–428. 181 indexed citations

17.

Bradner, William T., et al.. (1965). Antitumour Activity of N-(β,β′-dichlorodiethylaminomethyl)-tetra-cycline, ‘Tetracycline-mustard’. Nature. 205(4969). 399–400. 4 indexed citations

18.

Bradner, William T., et al.. (1965). Strain specificity of stimulated regression of sarcoma 180.. PubMed. 25(6). 859–64. 6 indexed citations

19.

Schmitz, H, William T. Bradner, A. Gourévitch, et al.. (1962). Actinogan: a new antitumor agent obtained from Streptomyces. I. Chemical and biological properties.. PubMed. 22. 163–6. 7 indexed citations

20.

Bradner, William T.. (1958). SPECIAL MICROBIOLOGICAL SYSTEMS, I. ANAEROBIC ORGANISMS*. Annals of the New York Academy of Sciences. 76(3). 469–474. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact